Fundraising Fox

ZAKA VC

Venture capital

San Francisco · Pre-Seed–Series A · 1 people tracked

Find your way into ZAKA VC

1,032 people in our graph share verified history with the ZAKA VC team — schools, employers, funds. One of them is your warm intro.

Patrick Claessenunlockedknows Andrej Petrus · together at London Business School
×8knows the team · via London Business School
knows the team · via Prague University of Economics and Business
×2knows the team · via Luiss Guido Carli University
Fox Verdict
Sign up to see your fit

Investment thesis

ZAKA VC is a seed and pre-seed venture fund that backs founders with global ambition regardless of location, aiming to build a bridge between North America and Europe. It invests mainly in the US and Europe, with a particular focus on the Health & Biotech and Industrial Tech verticals. The firm positions itself as founders backed by entrepreneurs, and has invested in 95 companies across five continents.

Source: firm website, verified Aug 3, 2026.

Stage
Pre-Seed–Series A
HQ
San Francisco, US
Instruments
Equity
Founded
2019
Last 12 months
3 investments
AUM
$16.5M
Tracked investments
88

Team · 1 people

from public directories

What they invest in

from 68 of 88 portfolio companies

AI & Machine Learning ×28Biotech ×21Healthtech ×19SaaS ×16Deep Tech ×15Enterprise Software ×15Advanced Manufacturing ×7Data & Infrastructure ×7

HQs:United States×25United Kingdom×8Germany×4Czechia×3Estonia×3Austria×2

Who they back

founder profiles across 51 portfolio companies
35%
solo founders
18 of 51 mapped founding teams
38%
repeat founders
of 73 founders with career history
~2 yrs
old at investment
median across 9 dated deals

Founding team size:solo founder×182 founders×253 founders×64+ founders×2

Where their founders studiedfrom 71 founders with education data

Imperial College London ×4Yale University ×4EPFL ×3Technische Universität Wien ×3UCL ×3University of California, Berkeley ×3University of Oxford ×3Birla Institute of Technology and Science, Pilani ×2

Where their founders worked beforefrom 73 founders with career history

Stanford University ×4Harvard Medical School ×3University of Oxford ×3Ambryx ×2Beam Therapeutics ×2Berkeley Lab ×2Bluebird Bio ×2EPFL (École polytechnique fédérale de Lausanne) ×2

Accelerator rootsportfolio companies that came through a program

Y Combinator ×23Techstars ×3

26 founders hold a PhD · 4 hold an MBA (of 73 with degree data)

Investments · 88 tracked

founders shown can be your intro path

By year:2026 · 22025 · 12024 · 42023 · 12022 · 12021 · 110 dated

Adentris
Alixiaalixia.cominJul 2024

Alixia develops therapeutics targeting tumor ecosystems to address cancer drug resistance and age-related diseases.

BiotechDeep TechHealthtechMedical DevicesSan Francisco, US

Olof Mollstedt(Founder)inHelen Chen(Founder)in

BoardSungwon Lim(Director)

Co-investorsY Combinator

Alpha3Dalpha3d.ioin𝕏
Appwebelappwebel.comin

Webel is an online marketplace that connects consumers with local professionals offering home services such as cleaning, private tutoring, beauty, and physiotherapy.

ConsumerFuture of WorkMarketplaces

Co-investorsTrind Ventures

Ateiosateios.comin𝕏

Ateios develops electrode manufacturing techniques designed to accelerate production speed, reduce carbon emissions, and decrease the physical footprint of battery manufacturing and gigafactories.

Advanced ManufacturingCleantechEnergyMedical DevicesNew MaterialsLa Jolla, US

Terry Taber(CTO)

Co-investorsCarat Venture PartnersCharmides CapitalElevate VenturesGood Growth CapitalHG VenturesTechstars+2 more

Avelis Healthavelishealth.comin𝕏

Avelis audits medical claims using AI and clinician review to identify billing, coding, and contract errors for health plans and third-party administrators.

AI & Machine LearningHealthtechInsurTech

Angel Onuoha(Founder)inAhmad Shehu(Founder)in

Co-investorsY CombinatorGFT Ventures

b-12
b12 Labsb12-labs.comin𝕏

b12 develops AI agents and lab automation software to help chemists plan, optimize, and execute the synthesis of complex molecules.

AI & Machine LearningBiotechDeep TechEnterprise SoftwareHealthtechRoboticsSan Francisco, US

Zlatko Jončev(Founder)inAndres Bran(Founder)in

Co-investorsY CombinatorTranspose Platform Management

Bit Biobit.bioin𝕏

bit.bio is a synthetic biology company that engineers human induced pluripotent stem cells into defined cell types for research, drug discovery, and cell therapy applications.

BiotechDeep TechHealthtechMedical Devices

Dr Mark Kotter(Founder)Przemek Obloj(CEO)inEmma Pepperellin

Co-investorsForesite CapitalBlueYard CapitalARCH Venture PartnersDynamk CapitalGood AI CapitalHAWKTAIL+2 more

Bizzon - Exitedmews.comin

Mews is a cloud-based hospitality platform and property management system (PMS) for hotels, covering booking, pre-arrival, check-in, in-stay purchases, point of sale, and check-out.

Cloud ComputingPropTechSaaSTravel & HospitalityPrague, CZ

Richard Valtr(Founder)in

Co-investorsBattery VenturesColumbia Lake PartnersNotion CapitalOutrun VenturesAtomico

Blockmateblockmate.ioin𝕏

Blockmate provides crypto infrastructure and compliance tools for banks and fintech companies, including portfolio management, payment integration, and AML compliance features accessible via a single API.

Crypto & Web3Enterprise SoftwareFintech

Ivan Hladik(Founder)in

Co-investorsBADideas.fundDEPO VenturesDiaspora VenturesBing VenturesBlockchain Founders FundNGC Ventures+1 more

Bluejaygetbluejay.aiin𝕏

Bluejay develops tools for improving the reliability of generative AI systems in production environments.

AI & Machine LearningDeveloper ToolsEnterprise SoftwareSan Francisco, US

Rohan Vasishth(Founder)inFaraz Siddiqi(Founder)in

Co-investorsFloodgateHomebrewY CombinatorRiverVest Venture Partners

boamboam.com

Boam AI provides managed, AI-native CRM data management using autonomous agents that verify, enrich, and continuously refresh business data on SMB and enterprise merchants.

AI & Machine LearningData & InfrastructureSales Tech

Daniel P.(Founder)inStuart Murless(Founder)in

Co-investorsDorm Room

Bullseye Biosciencesbullseyebiosciences.comin

Bullseye Biosciences uses in-cell directed evolution to discover functional therapeutic molecules against challenging intracellular targets such as protein–protein interactions and transcriptional regulation.

BiotechDeep Tech

Corey Gray(Co-founder and CEO)inMichael McKeown(Co-founder and Head of Research)in

Co-investorsIllumina Ventures

CellTypecelltype.comin

CellType uses AI agents and biological models to automate drug discovery, having identified a novel cancer treatment signal and partnering with major pharmaceutical companies.

BiotechHealthtechNew York City, US

David van Dijk(Co-Founder & CEO)inIvan Vrkic(Co-Founder)in

Co-investorsACVC PartnersY Combinator

Cirrus Therapeutics
Cirrustxcirrustx.comin

Cirrus Therapeutics is a biotech developing gene and cell therapies based on ocular immunology to treat dry age-related macular degeneration (AMD), including an AAV gene therapy to restore the IRAK-M immune regulator and a next-generation retinal pigment epithelium (RPE) cell therapy for advanced geographic atrophy.

BiotechHealthtechLongevityCambridge, US

Ying Kai Chan(Co-founder & CEO)in

Conntacconntac.netin

Conntac provides a self-service platform for customer support, enabling end users and service teams to resolve issues independently while helping companies reduce support costs and improve customer satisfaction.

Enterprise SoftwareSaaSGermany, DE

Co-investorsBasinghall PartnersBayern Kapital

CorpLifecorplife.atin

Corplife is a digital HR platform that helps companies of all sizes digitalize employee processes, including benefits administration and tax-free meal subsidies.

Enterprise SoftwareHR TechSaaSVienna, AT

David(Co-Founder / New Business)Mario

Creasalliscreasallis.com𝕏

Creasallis develops CreaTap, a patented "plug-and-play" antibody modification technology that improves the penetration of antibody-based drugs into solid tumours, applicable to monoclonal, bispecific, and antibody-drug conjugates.

Biotech

Zahra Jawad(Founder)in

Co-investorsBlueYard CapitalPace VenturesKdT Ventures

CRUXOcruxo.ioin

CRUXO provides a retail media platform and consultancy that helps retailers and brands launch and scale retail media using proprietary data insights.

AdTechMarketing TechRetail TechPrague, CZ

Michal Trunkát(Founder & CEO)inJan Galgonek(Managing Partner and Co-Founder)inHana Pavlíková(Chief Customer Officer)inJakub Špryngl(Chief Commercial Officer)inJiří Pětvaldský(Chief Technology Officer)inLenka Trunkátová(Chief of Consultancy)in

Co-investorsPresto VenturesRockaway Ventures

Deepseqdeepseq.ai

DeepSeq designs biologic drugs using AI trained on massive datasets of real protein interactions, predicting properties such as affinity, specificity, immunogenicity, pharmacokinetics, and manufacturability.

AI & Machine LearningBiotechDeep Tech

Bernhard Suter(Founder)in

Co-investorsIllumina Ventures

Deskree
E Mobilioe-mobilio.dein

e-mobilio provides a digital ecosystem for electric mobility, offering fleet electrification, charging infrastructure, billing systems, and a digital purchase advisor with product matching for EV charging stations and wallboxes.

CleantechEnergyMobility & Transportation

Co-investorsSeed+SpeedÜbermorgen VenturesVireo Ventures

Easy Saleseasy-sales.comin

easySales enables sellers to list and manage products across multiple online marketplaces through API integration without technical expertise.

E-commerceMarketing TechRetail TechSaaS

Ciprian Cazacu(Co-founder)inIulian CazacuinSzocs Szilard

EdgeTraceedgetrace.aiin𝕏

EdgeTrace provides AI-powered video search software that allows law enforcement and public safety agencies to query video footage in plain language, finding answers in seconds instead of hours of manual review.

AI & Machine LearningDefense TechEnterprise SoftwareGovTechSan Francisco, US

Kyle Orciuch(Co-Founder & CEO)in

Co-investorsY Combinator

Eigen Therapeutics
Eigentxeigentx.comin𝕏

Eigen develops co-therapies that modulate cancer cell target expression to improve the effectiveness of targeted treatments such as antibody-drug conjugates and radioligand therapies.

AI & Machine LearningBiotechRoboticsRedwood City, US

Co-investorsSBXi

Excepgenexcepgen.com

ExcepGen develops biologics, gene therapies, and vaccines using synthetic biology approaches to create therapies that operate outside normal cellular regulation constraints.

AI & Machine LearningBiotechHealthtechSan Francisco, US

Thomas Folliard(Founder)in

Co-investorsOxonian VenturesPi CampusY Combinator

Exomatterexomatter.aiinOct 2024

ExoMatter builds a software platform for materials research and development, providing tools to help scientists discover and evaluate materials faster.

AI & Machine LearningDeep TechNew MaterialsMunich, DE

Josua Vieten(Founder)in

Co-investorsBayern KapitalBloomhaus VenturesGF BRYCK VenturesTechFounders

FinalDosefinaldose.aiin𝕏

FinalDose develops a programmable DNA-targeting molecule designed to recognize and destroy cells carrying specific genetic sequences, with initial applications in oncology across cancer types.

AI & Machine LearningBiotechHealthtechLondon, GB

Li-Yao Huang(Founder)inSteven Lin(Founder)inJeff Liu(Founder)in

Co-investorsLobster CapitalScribble VenturesY Combinator

Flexkeeping
GitGutgitgut.ai

Co-investorsDEPO Ventures

Human Archivehumanarchive.aiin

Human Archive is a data lab that collects, labels, and synchronizes multimodal sensor data (video, audio, tactile, motion capture) from 100,000+ contributors across homes, hospitality, agriculture, industrial, construction, and retail settings.

Advanced ManufacturingAI & Machine LearningData & InfrastructureDeep TechRoboticsSan Francisco, US

Raj Patel(Founder)inRushil Agarwal(Founder)inSamay Maini(Founder)inShloke Patel(Founder)in

Co-investorsY CombinatorNVP CapitalWing

InGel TherapeuticsJul 2022

BiotechCambridge, US

Myron Spector(Director)Pierre Colombe Dromel(Executive Officer, Director)Deepti Singh(Director)Michael Young(Director)

InGel Websiteingeltx.comin

InGel Therapeutics develops engineered cell therapies for complex retinal degenerative diseases, combining retinal precursor cells with a biomimetic hyaluronic acid and gelatin hydrogel delivery matrix that mimics the human vitreous.

BiotechDeep TechHealthtech

Patrick Jiang(CEO & Co-founder)inPierre Colombe Dromel(Chief Technology Officer & Co-founder)inDeepti Singh(Chief Scientific Officer & Co-founder)in

Co-investorsMassVenturesService Provider CapitalThe Venture Collective

Inversion Semiconductorinversionsemi.comin𝕏

Inversion Semiconductor develops next-generation semiconductor lithography equipment based on miniaturized particle accelerators that increase transistor density and improve chip manufacturing precision.

Advanced ManufacturingDeep TechHardwareRoboticsSemiconductorsSan Francisco, US

Rohan Karthik(CEO)inDaniel Vega(CTO)inRohan Shishir Karthik(CEO)inDaniel Ricardo Vega Bermudez(CTO)in

Co-investorsAnorak VenturesEntrepreneur FirstLobster CapitalMoonfire VenturesMyAsiaVCTranspose Platform Management+2 more

Kangaroo Biomedical
Kano Therapeuticskanotherapeutics.comin𝕏May 2024

Kano Therapeutics develops circular single-stranded DNA (cssDNA) as a genetic payload for gene-editing and other DNA-based therapies, offering an alternative to viral vectors and double-stranded DNA.

BiotechDeep TechCambridge, US

Floris Engelhardt(Executive Officer, Director)John Vroom(Director)

BoardAnn DeWitt(Director)in

Co-investorsFifty YearsLaunchpad Venture GroupMetaplanetThe Engine VenturesVsquared Ventures

KiraGen
KiraGen Biokiragenbio.comin

KiraGen Bio develops cell-therapy approaches aimed at treating brain cancers, with a focus on therapies designed to remain functional under suppressive tumor conditions.

AI & Machine LearningBiotechDeep TechHealthtech

Aaron Edwards(Co-Founder & Chief Executive Officer)inRyan Murray, PhD(Founder)in

Co-investors2048 VenturesFifty Years

Lime Therapeuticslimetherapeutics.cominApr 2024

Lime Therapeutics is a biotechnology company developing lipid-altering medicines for cancer, cardiometabolic diseases, lysosomal storage diseases, and neurodegenerative disorders.

BiotechMedical DevicesNew York, US

Prakrit V. Jena(Co-founder & CTO)inShardule Shah(CEO)in

Co-investorsHBS Angels of Boston

LunaBilllunabill.comin𝕏

LunaBill provides AI automation software for hospital billing teams to manage denied claims and patient revenue cycles.

AI & Machine LearningEnterprise SoftwareHealthtechSaaSSan Francisco, US

Suhail Parry(Founder)inDavid Day(Founder)in

Co-investorsFoundersGarage CapitalLobster CapitalY Combinator

Mbodi AImbodi.aiin𝕏

Mbodi develops AI-powered robots that can learn new tasks through natural language instructions and demonstration, eliminating the need for reprogramming when processes change.

Advanced ManufacturingAI & Machine LearningRoboticsNew York City, US

Xavier (Tianhao) Chi(Founder)inSebastian Peralta(Founder)in

Co-investorsACADEMY INVESTORAIN VenturesBetaworksFuel Venture CapitalImagination CapitalMozilla Ventures+6 more

MediSearchmedisearch.ioin𝕏

MediSearch provides instant answers to medical questions sourced from reliable medical information.

AI & Machine LearningDigital HealthHealthtechWellness & FitnessLondon, GB

Eduard Oravkin(Founder)inMichal Pándy(Founder)in

Co-investorsAmino CapitalKAYAY Combinator

Memtimememtime.comin

Memtime is a desktop application that passively tracks time spent across programs to help users create time entries and log hours, with integration capabilities to project management tools like Teamwork.

Developer ToolsEnterprise SoftwareFuture of WorkSaaS

Arne Reimann(Founding Partner & CEO)inMislav Boras(Founding Partner & CTO)inNiclas Preisner(Founding Partner & CMO)in

Co-investorsBayern Kapital

Miros AImiros.aiin

Miros builds an AI-driven product discovery technology that infers shopper intent from behavioural signals such as scroll velocity, clicks, and dwell time, rather than requiring shoppers to describe what they want.

AI & Machine LearningE-commerceRetail TechTallinn, EE

Co-investorsTera VenturesBADideas.fundMetis VenturesSnatched VenturesSpecialist VC

Momentous Therapeuticsmomentous-therapeutics.com

Cambridge, GB

Co-investorsBlueYard Capital

Nephrogennephrogenbiotech.cominNov 2025

Nephrogen develops AI-powered AAV delivery vehicles for genetic medicines targeting kidney and pancreatic diseases.

AI & Machine LearningBiotechData & InfrastructureHealthtechMedical DevicesNew York City, US

Demetri Maxim(Founder and CEO)Vivek Bhalla(Chief Medical Officer)

Co-investorsTechstarsY Combinator

Olio Labsoliolabs.coin

Olio Labs develops drug combination therapies using machine learning to identify treatments that target multiple interacting proteins simultaneously, with initial candidates focused on obesity treatment.

BiotechHealthtech

David Tingley(Founder)inTom Roseberry(Founder)in

Co-investorsOverwater Ventures LlcSciFoundersScrum VenturesY Combinator

Orderlionorderlion.comin

Orderlion provides an eCommerce and order-management platform for food & beverage wholesalers and distributors, offering a branded online ordering app, ERP integration, customer-specific pricing, sales analytics, and an AI inbox that converts email, WhatsApp, and voicemail orders into integrated orders.

E-commerceFoodTechSaaS

Patrick Schubert(Founder)in

Co-investorsAxeleo CapitalBloomhaus VenturesRockstartSeed+SpeedSICTIC

ParcelBioparcelbio.cominFeb 2026 · $13M

ParcelBio develops APEXm, a proprietary mRNA platform that enhances protein expression for longer-lasting therapeutic effect compared to conventional mRNA technologies.

AI & Machine LearningBiotechDeep TechHealthtechSan Francisco, US

David Weinberg(Founder)inChris Carlson(Founder)in

BoardMorgan Cheatham(Director)in

Co-investorsY CombinatorBreyer CapitalGeneral CatalystLexi VenturesMetaplanetNorth South Ventures+3 more

PerfectBit, Inc.perfectbit.aiin𝕏

Perfectbit generates high-quality, information-dense synthetic data for AI model training using formal proof systems, simulators, and executable tests rather than human annotation.

AI & Machine LearningData & InfrastructureEnterprise SoftwareSan Francisco, US

Seiji Yamamoto(Founder)inPeter Vajda(Founder)in

Co-investorsImagination CapitalY Combinator

Positive Carbonpositivecarbon.orgin𝕏

Positive Carbon makes Scrappy-1, an autonomous AI-powered robot and analytics platform that monitors, identifies, weighs, and prices food waste in commercial kitchens.

AI & Machine LearningClimate TechFoodTech

Co-investorsBusiness Venture PartnersHeartfelt Capital

ProGradprograd.ukin𝕏

Prograd is a digital platform that compares and recommends investment accounts tailored to individual financial goals and budgets.

AI & Machine LearningConsumerEdTechFintechGamingLondon, GB

Ethan Fraenkel(Founder)in

Co-investorsEv3 Ventures LlcTechstars

Promakhos
Promakhos Therapeuticspromakhos.comin𝕏Mar 2021

Promakhos Therapeutics develops immunomodulatory therapies to restore immune system balance and reduce chronic inflammation in diseases like Crohn's disease, ankylosing spondylitis, and psoriasis.

BiotechHealthtechBoston, US

Katerina Chatzi(Founder)inJasper Edgar Neggers(Founder)inAIKATERINI CHATZI(Executive Officer, Director, Promoter)

Co-investorsFoundersMetaplanetY Combinator

Readmioreadmio.comin𝕏

Readmio is a voice-reactive storytelling app that reads illustrated fairy tales and stories to children, adding sound effects and music that respond to the reader's voice for an interactive bedtime experience.

ConsumerEdTechMedia & Entertainment

Jozef Šimko(Founder)in

Co-investorsSimpact VenturesDEPO VenturesZero Gravity Capital

Rendinrendin.eein

Rendin provides rental property management and protection services for landlords in Estonia and Poland, offering background-checked tenants, financial guarantees against unpaid rent and property damage, and legal support throughout the rental process.

B2B MarketplacesFintechInsurTechLegalTechPropTechSaaSTallinn, EE

Alain Aun(CEO and co-founder)inMaiko Saluorg(Co-founder and marketing lead)in

Co-investorsIron Wolf Capital

Portfolio news

latest coverage across their companies

Frequently asked questions

How many investments has ZAKA VC made?
ZAKA VC has 88 tracked investments, including 4 dated in the last 24 months.
What stage does ZAKA VC invest at?
ZAKA VC invests at the Pre-Seed, Seed, Series A stages.
What sectors does ZAKA VC focus on?
ZAKA VC focuses on Advanced Manufacturing, AI & Machine Learning, Biotech, Climate Tech, Deep Tech, Enterprise Software, Fintech, Healthtech, Robotics, SaaS, Sector Agnostic.
Where is ZAKA VC located?
ZAKA VC is headquartered in San Francisco, US.
Who does ZAKA VC co-invest with?
ZAKA VC most often shares deals with Y Combinator, DEPO Ventures, Metaplanet, among 130 tracked co-investors.

Images

ZAKA VC photo

Co-investors · 8

BlueYard Capital

Blueyard is a small equal partnership with offices in the US and Europe, investing in early-stage companies.

Both backed · 4
$500K – $5M
Trind Ventures

Trind Ventures is an early-stage venture capital firm that backs consumer and community-driven startups across Europe, supporting founders from the first investment through multiple rounds.

Both backed · 1
$108K – $1.1M
Andreessen Horowitz

Andreessen Horowitz (a16z) is a venture capital firm founded in 2009 by Marc Andreessen and Ben Horowitz, known for pioneering the platform model with a large team of operators supporting founders across stages.

$500K – $50M
Alumni Ventures

Alumni Ventures (AV) is a venture capital firm that co-invests alongside lead VCs in startups, backing founders with capital and access to a large investor and operator community.

$100K – $10M
Pioneer

Pioneer Fund is a venture capital firm investing in the top Y Combinator startups.

Forum Ventures

Forum Ventures is a founder-first venture studio, accelerator, and pre-seed fund focused on early-stage B2B software startups, providing hands-on support from concept through first fundraising round.

$50K – $100K
MizMaa Ventures

MizMaa Ventures is an early-stage, thesis-driven venture capital firm backing Israeli entrepreneurs building deep-technology solutions, offering hands-on support alongside long-term capital.

$1M – $6M
SeaX Ventures

SeaX Ventures is a globally focused venture capital fund backing early-stage companies developing exponential and deep-tech technologies, with a strategic emphasis on bridging the U.S. and Southeast Asia.

$100K – $5M

Firms observed investing alongside ZAKA VC, from public investor directories. Shared companies are the overlap with ZAKA VC's recorded portfolio.

Similar investors

Featured in lists